Table 1.

Key clinical event rates from post hoc analysis of phase 3 cinacalcet studies (24)

Clinical OutcomeCinacalcet (Events per 100 Patient-Years)Control (Events per 100 Patient-Years)HR (95% CI)aP for HR
Parathyroidectomy0.34.10.07 (0.01 to 0.55)0.009
Fracture3.26.90.46 (0.22 to 0.95)0.040
Cardiovascular hospitalization15.019.70.61 (0.43 to 0.86)0.005
Mortality5.27.40.81 (0.45 to 1.45)0.470
  • a Control is used as the reference group. CI, confidence interval; HR, hazard ratio.